Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary

About the Drug Formulary Email Drug Formulary Team

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

Filtered By:

X Remove topotecan filter topotecan
X Remove methotrexate filter methotrexate
X Remove oBINutuzumab filter oBINutuzumab
X Remove thioguanine filter thioguanine
X Remove 2018 filter 2018

4 Items

CHLO+OBIN

Cancer Type: Hematologic, Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - Previously Untreated Chronic Lymphocytic Leukemia

ODB - General Benefit

chlorambucil

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2018

CHLO+OBIN

Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

chlorambucil

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2018

CYCLTOPO

Cancer Type: Sarcoma, Ewing's, Soft Tissue
Intent: Palliative

Drugs Used:

cyclophosphamide,

topotecan (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2018

MTRX(IT)

Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML), Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative, Curative

Drugs Used:

methotrexate

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2018